Adults with type 2 diabetes may be more likely to report smell and taste disturbances if they were prescribed a GLP-1 receptor agonist, according to data published in JAMA Otolaryngology – Head & Neck Surgery. In an analysis of data from the TriNetX electronic health records database, researchers compared smell and taste disturbances among adults with type 2 diabetes who were prescribed a

Adults with type 2 diabetes may be more likely to report smell and taste disturbances if they were prescribed a GLP-1 receptor agonist, according to data published in JAMA…

GLP-1 receptor agonists were associated with a higher risk for eye complications vs. other diabetes medications, two studies recently published in Annals of Internal Medicine…